St. John’s wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells

References

• Barnes J, Anderson LA, Phillipson JD. 2001. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 53:583–600.
   PubMed Web of Science ®Google Scholar
• Barten LJ, Allington DR, Procacci KA, Rivey MP. 2010. New approaches in the management of multiple sclerosis. Drug Design Devel Ther. 4:343.
   PubMed Web of Science ®Google Scholar
• Batoulis H, Addicks K, Kuerten S. 2010. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T H 1 paradigm. Ann Anat-Anatom Anzeiger. 192:179–193.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Chakrabarti A, Chatterjee S. 1998. Activity profiles of two hyperforin-containing hypericum extracts in behavioral models. Pharmacopsychiatry. 31:22–29.
   PubMed Web of Science ®Google Scholar
• Bray BJ, Brennan NJ, Perry NB, Menkes D, Rosengren R. 2002. Short-term treatment with St. John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in Swiss Webster mouse. Life Sci. 70:1325–1335.
   PubMed Web of Science ®Google Scholar
• Brück W. 2005. Pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neuro. 252:v3–v9.
   Web of Science ®Google Scholar
• Cabrelle A, Dell’aica I, Melchiori L, Carraro S, Brunetta E, Niero R, Scquizzato E, D Intino G, Calzà L, Garbisa S. 2008. Hyperforin down-regulates effector function of activated T-lymphocytes and shows efficacy against TH1-triggered CNS inflammatory-demyelinating disease. J Leukocyte Biol. 83:212–219.
   PubMed Web of Science ®Google Scholar
• Corsini E, Oukka M, Pieters R, Kerkvliet NI, Ponce R, Germolec DR. 2011. Alterations in regulatory T-cells: Re-discovered pathways in immunotoxicology. J Immunotoxicol. 8:251–257.
   PubMed Web of Science ®Google Scholar
• Cristofanilli M, Rosenthal H, Cymring B, Gratch D, Pagano B, Xie B, Sadiq SA. 2014. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice. Exp Neurol. 261:620–632.
   PubMed Web of Science ®Google Scholar
• Dell’aica I, Niero R, Piazza F, Cabrelle A, Sartor L, Colalto C, Brunetta E, Lorusso G, Benelli R, Albini A. 2007. Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angio-genesis and lung fibrosis. J Pharmacol Exp Ther. 321:492–500.
   PubMed Web of Science ®Google Scholar
• Fritzsching B, Haas J, König F, Kunz P, Fritzsching E, Pöschl J, Krammer PH, Brück W, Suri-Payer E, Wildemann B. 2011. Intracerebral human regulatory T-cells: Analysis of CD4+CD25+FoxP3+ T-cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients. PLoS One. 6:e17988.
   Web of Science ®Google Scholar
• Gibon J, Deloulme JC, Chevallier T, Ladeveze E, Abrous DN, Bouron A. 2013. The anti-depressant hyperforin increases the phosphorylation of CREB and expression of TrkB in a tissue-specific manner. Intl J Neuropsychopharmacol. 16:189–198.
   PubMed Web of Science ®Google Scholar
• Gomez Del Rio M, Sánchez-Reus M, Iglesias I, Pozo M, Garcia-Arencibia M, Fernandez-Ruiz J, García-García L, Delgado M, Benedí J. 2013. Neuroprotective properties of standardized extracts of Hypericum perforatum on rotenone model of Parkinson’s disease. CNS Neurol Disorders. 12:665–679.
   PubMed Web of Science ®Google Scholar
• Haghmorad D, Amini AA, Mahmoudi MB, Rastin M, Hosseini M, Mahmoudi M. 2014. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and TH2 cells. J Neuroimmunol. 277:85–95.
   PubMed Web of Science ®Google Scholar
• Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung H-P. 2006. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat. Clin. Practice Neurol. 2:201–211.
   PubMedGoogle Scholar
• Kawakami N, Bartholomäus I, Pesic M, Mues M. 2012. An autoimmunity odyssey: How autoreactive T-cells infiltrate into the CNS. Immunol Rev. 248:140–155.
   PubMed Web of Science ®Google Scholar
• Koutrolos M, Berer K, Kawakami N, Wekerle H, Krishnamoorthy G. 2014. Treg cells mediate recovery from EAE by controlling effector T-cell proliferation and motility in the CNS. Acta Neuropathol Commun. 2:163.
   PubMedGoogle Scholar
• Kraus B, Wolff H, Heilmann J, Elstner EF. 2007. Influence of Hypericum perforatum extract and its single compounds on amyloid-β-mediated toxicity in microglial cells. Life Sci. 81:884–894.
   PubMed Web of Science ®Google Scholar
• Markoullis K, Sargiannidou I, Gardner C, Hadjisavvas A, Reynolds R, Kleopa KA. 2012. Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalo-myelitis. Glia. 60:1053–1066.
   PubMed Web of Science ®Google Scholar
• Meinke MC, Schanzer S, Haag SF, Casetti F, Müller ML, Wölfle U, Kleemann A, Lademann J, Schempp CM. 2012. In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high anti-oxidant activity in vitro and ex vivo. Eur J Pharm Biopharm. 81:346–350.
   PubMed Web of Science ®Google Scholar
• Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK. 2010. Animal models of multiple sclerosis – potentials and limitations. Prog Neurobiol. 92:386–404.
   PubMed Web of Science ®Google Scholar
• Mohanasundari M, Sabesan M. 2007. extract on astrocytes in MPTP induced Parkinson’s disease in mice. Eur Rev Med Pharmacolog Sci. 11:17–20.
   PubMed Web of Science ®Google Scholar
• Mondal S, Pahan K. 2015. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T-cells: Implications for Multiple Sclerosis therapy. PLoS One 10:e0116566.
   PubMed Web of Science ®Google Scholar
• Moreno B, Hevia H, Santamaria M, Sepulcre J, Muñoz J, García-Trevijano ER, Berasain C, Corrales FJ, Avila MA, Villoslada P. 2006. Methylthioadenosine reverses brain auto-immune disease. Ann Neurol. 60:323–334.
   PubMed Web of Science ®Google Scholar
• Mozaffari S, Esmaily H, Rahimi R, Baeeri M, Sanei Y, Asadi-Shahmirzadi A, Salehi-Surmaghi M-H, Abdollahi M. 2011. Effects of Hypericum perforatum extract on rat irritable bowel syndrome. Pharmacog Mag. 7:213.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. 2006. FoxP3+CD25+CD4+ natural regulatory T-cells in dominant self‐tolerance and autoimmune disease. Immunol Rev. 212:8–27.
   PubMed Web of Science ®Google Scholar
• Schneider C, Schuetz G, Zollner TM. 2009. Acute neuroinflammation in Lewis rats: A model for acute multiple sclerosis relapses. J Neuroimmunol. 213:84–90.
   PubMed Web of Science ®Google Scholar
• Soellner IA, Rabe J, Mauri V, Kaufmann J, Addicks K, Kuerten S. 2013. Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis. Clin Immunol. 149:519–529.
   PubMed Web of Science ®Google Scholar
• Stadelmann C, Wegner C, Brück W. 2011. Inflammation, demyelination, and degeneration – recent insights from MS pathology. Biochim Biophys Acta. 1812:275–282.
   PubMed Web of Science ®Google Scholar
• Süntar IP, Akkol EK, Yılmazer D, Baykal T, Kirmizibekmez H, Alper M, Yesilada E. 2010. Investigations on the in vivo wound healing potential of Hypericum perforatum L. J Ethnopharmacol. 127:468–477.
   PubMed Web of Science ®Google Scholar
• Wolfle U, Seelinger G, Schempp CM. 2014. Topical application of St. John's wort (Hypericum perforatum). Planta Med. 80:109–120.
   PubMed Web of Science ®Google Scholar